Join our webinar for insights on the journey from preclinical to clinical studies in pulmonary arterial hypertension (PAH), and much more.
This webinar represents a collective effort to propel the knowledge exchange within our community. It offers a unique opportunity to deepen your understanding, engage in critical discussions, and foster collaborations in this rapidly evolving field.
Distinguished experts from University Hospital of Antwerp and SGS, unravel the latest advancements from preclinical to clinical studies in pulmonary arterial hypertension (PAH). They will give profound insights into current treatments, late-phase Investigational Medicinal Products (IMPs) and early-stage innovations tailored for this indication.
Target Audience: The webinar is aimed at all pharmaceutical and biotech professionals, as well as esteemed pulmonologists, general practitioners, cardiologists and clinicians.
Language: English
Can't make a live session? Register now and receive a complimentary recording after the live event.
